최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Neurosurgical Society = 대한신경외과학회지, v.64 no.4, 2021년, pp.631 - 643
Kwon, Ji-Woong (Neuro-oncology Clinic, National Cancer Center) , Shim, Youngbo (Department of Neurosurgery, Seoul National University College of Medicine) , Gwak, Ho-Shin (Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy) , Park, Eun Young (Biostatistics Collaboration Team, National Cancer Center) , Joo, Jungnam (Biostatistics Collaboration Team, National Cancer Center) , Yoo, Heon (Neuro-oncology Clinic, National Cancer Center) , Shin, Sang-Hoon (Neuro-oncology Clinic, National Cancer Center)
Objective : Here, we evaluated whether cerebrospinal fluid (CSF) profiles and their changes after intraventricular chemotherapy for leptomeningeal carcinomatosis (LMC) could predict the treatment response or be prognostic for patient overall survival (OS) along with clinical factors. Methods : Paire...
1 Ahn JH Lee SH Kim S Joo J Yoo H Lee SH Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection J Neurosurg 116 984 993 2012 22339161
2 An YJ Cho HR Kim TM Keam B Kim JW Wen H An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients Int J Cancer 136 162 171 2015 24798643
3 Balm M Hammack J Leptomeningeal carcinomatosis. Presenting features and prognostic factors Arch Neurol 53 626 632 1996 8929170
4 Boogerd W Hart AA van der Sande JJ Engelsman E Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment Cancer 67 1685 1695 1991 2001559
5 Boogerd W van den Bent MJ Koehler PJ Heimans JJ van der Sande JJ Aaronson NK The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study Eur J Cancer 40 2726 2733 2004 15571954
6 Bruna J Gonzalez L Miro J Velasco R Gil M Tortosa A Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features Cancer 115 381 389 2009 19109820
7 Chamberlain MC Radioisotope CSF flow studies in leptomeningeal metastases J Neurooncol 38 135 140 1998 9696363
8 Chamberlain MC Leptomeningeal metastasis Curr Opin Oncol 22 627 635 2010 20689429
9 Chamberlain MC Glantz M Groves MD Wilson WH Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment Semin Oncol 36 4 Suppl 2 S35 S45 2009 19660682
10 Chamberlain MC Kormanik P Carcinoma meningitis secondary to nonsmall cell lung cancer: combined modality therapy Arch Neurol 55 506 512 1998 9561978
11 Chamberlain MC Kormanik PA Glantz MJ A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases Neuro Oncol 3 42 45 2001 11305416
12 Clamon G Doebbeling B Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement Breast Cancer Res Treat 9 213 217 1987 3663957
13 de Azevedo CR Cruz MR Chinen LT Peres SV Peterlevitz MA de Azevedo Pereira AE Meningeal carcinomatosis in breast cancer: prognostic factors and outcome J Neurooncol 104 565 572 2011 21234642
14 Fizazi K Asselain B Vincent-Salomon A Jouve M Dieras V Palangie T Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen Cancer 77 1315 1323 1996 8608509
15 Freilich RJ Krol G DeAngelis LM Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 51 57 1995 7611725
16 Gauthier H Guilhaume MN Bidard FC Pierga JY Girre V Cottu PH Survival of breast cancer patients with meningeal carcinomatosis Ann Oncol 21 2183 2187 2010 20430906
17 Glantz MJ Hall WA Cole BF Chozick BS Shannon CM Wahlberg L Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status Cancer 75 2919 2931 1995 7773943
18 Glass JP Melamed M Chernik NL Posner JB Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology Neurology 29 1369 1375 1979 573381
19 Gleissner B Chamberlain MC Neoplastic meningitis Lancet Neurol 5 443 452 2006 16632315
20 Grossman SA Krabak MJ Leptomeningeal carcinomatosis Cancer Treat Rev 25 103 119 1999 10395835
21 Groves MD Glantz MJ Chamberlain MC Baumgartner KE Conrad CA Hsu S A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies Neuro Oncol 10 208 215 2008 18316473
22 Gwak HS Joo J Kim S Yoo H Shin SH Han JY Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer J Thorac Oncol 8 599 605 2013 23422833
23 Gwak HS Joo J Shin SH Yoo H Han JY Kim HT Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: a phase II study Oncologist 19 1044 1045 2014 25209375
24 Harstad L Hess KR Groves MD Prognostic factors and outcomes in patients with leptomeningeal melanomatosis Neuro Oncol 10 1010 1018 2008 18708343
25 Herrlinger U Forschler H Kuker W Meyermann R Bamberg M Dichgans J Leptomeningeal metastasis: survival and prognostic factors in 155 patients J Neurol Sci 223 167 178 2004 15337619
26 Hitchins RN Bell DR Woods RL Levi JA A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis J Clin Oncol 5 1655 1662 1987 3309199
27 Hyun JW Shin HS Kim SH Kong SY Yoo H Gwak HS CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: a pilot study Cancer Biomark 28 81 89 2020 32176621
28 Jayson GC Howell A Carcinomatous meningitis in solid tumours Ann Oncol 7 773 786 1996 8922190
29 Lee JS Melisko ME Magbanua MJ Kablanian AT Scott JH Rugo HS Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer Breast Cancer Res Treat 154 339 349 2015 26520840
30 Lin NU Lee EQ Aoyama H Barani IJ Barboriak DP Baumert BG Response assessment criteria for brain metastases: proposal from the RANO group Lancet Oncol 16 e270 e278 2015 26065612
31 Morris PG Reiner AS Szenberg OR Clarke JL Panageas KS Perez HR Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy J Thorac Oncol 7 382 385 2012 22089116
32 Nakagawa H Kubo S Murasawa A Nakajima S Nakajima Y Izumoto S Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors J Neurooncol 12 111 120 1992 1560255
34 Singh SK Agris JM Leeds NE Ginsberg LE Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging Radiology 217 50 53 2000 11012422
35 Singh SK Leeds NE Ginsberg LE MR imaging of leptomeningeal metastases: comparison of three sequences AJNR Am J Neuroradiol 23 817 821 2002 12006284
36 Taillibert S Laigle-Donadey F Chodkiewicz C Sanson M Hoang-Xuan K Delattre JY Leptomeningeal metastases from solid malignancy: a review J Neurooncol 75 85 99 2005 16215819
37 Teplyuk NM Mollenhauer B Gabriely G Giese A Kim E Smolsky M MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity Neuro Oncol 14 689 700 2012 22492962
38 Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 2000 10655437
39 Tu Q Wu X Le Rhun E Blonski M Wittwer B Taillandier L CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis Lung Cancer 90 352 357 2015 26386833
40 Twijnstra A van Zanten AP Hart AA Ongerboer de Visser BW Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours J Neurol Neurosurg Psychiatry 50 313 320 1987 3559613
41 Waki F Ando M Takashima A Yonemori K Nokihara H Miyake M Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors J Neurooncol 93 205 212 2009 19043775
42 Wasserstrom WR Glass JP Posner JB Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients Cancer 49 759 772 1982 6895713
43 Wen PY Macdonald DR Reardon DA Cloughesy TF Sorensen AG Galanis E Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 1963 1972 2010 20231676
44 Yap HY Yap BS Rasmussen S Levens ME Hortobagyi GN Blumenschein GR Treatment for meningeal carcinomatosis in breast cancer Cancer 50 219 222 1982 6177395
45 Yousem DM Patrone PM Grossman RI Leptomeningeal metastases: MR evaluation J Comput Assist Tomogr 14 255 261 1990 2312855
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.